
Relapse Following CAR T-cell Therapy Linked to Poor OS in Relapsed/Refractory Myeloma
August 27, 2022Lisa AstorRelapse following treatment with BCMA-directed CAR T-cell therapy was associated with poor survival outcomes in patients with relapsed/refractory multiple myeloma.Multiple Mye
Updated on: October 24,2023
31

Relapse Following CAR T-cell Therapy Linked to Poor OS in Relapsed/Refractory Myeloma
August 27, 2022Lisa AstorRelapse following treatment with BCMA-directed CAR T-cell therapy was associated with poor survival outcomes in patients with relapsed/refractory multiple myeloma.Multiple Mye
Updated on:October 24,2023
31
